Equities

PsyBio Therapeutics Corp

PsyBio Therapeutics Corp

Actions
  • Price (CAD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Dec 07 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Psybio Therapeutics Corp share price to rise to 2.00 in the next year from the last price of 0.01.
High19,900.0%2.00
Med19,900.0%2.00
Low19,900.0%2.00

Earnings history & estimates in CAD

On Aug 29, 2022, Psybio Therapeutics Corp reported 2nd quarter 2022 losses of -0.013 per share. This result was in line with the expectation of the one analyst following the company and exceeded last year's 2nd quarter results by 67.50%.
Average growth rate+50.00%
Psybio Therapeutics Corp reported annual 2021 losses of -0.10 per share on Mar 02, 2022.
More ▼

Revenue history & estimates in CAD

Revenue forecasts are not available for Leo Acquisitions Corp..
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.